Screener
Bausch Health Companies BHC Diversified — SG&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| (in millions) | Three Months Ended March 31, / Salix / 2026 | Three Months Ended March 31, / Salix / 2025 | Three Months Ended March 31, / International / 2026 | Three Months Ended March 31, / International / 2025 | Three Months Ended March 31, / Solta Medical / 2026 | Three Months Ended March 31, / Solta Medical / 2025 | Three Months Ended March 31, / Diversified / 2026 | Three Months Ended March 31, / Diversified / 2025 | Three Months Ended March 31, / Bausch + Lomb / 2026 | Three Months Ended March 31, / Bausch + Lomb / 2025 | Three Months Ended March 31, / Total / 2026 | Total / 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Less: | ||||||||||||
| Cost of goods sold (a) | 47 | 43 | 112 | 102 | 53 | 27 | 27 | 30 | 482 | 481 | ||
| Cost of other revenues | — | — | 16 | 17 | — | — | — | — | 1 | 1 | ||
| Selling, general and administrative | 105 | 111 | 63 | 52 | 35 | 28 | 43 | 45 | 439 | 447 | ||
| Research and development | 19 | 17 | 6 | 6 | 8 | 5 | 3 | 3 | 45 | 28 | ||
| Segment profit | $468 | $371 | $88 | $85 | $75 | $53 | $112 | $127 | $277 | $180 | $1,020 | $816 |
| Corporate | (258) | (268) | ||||||||||
| Amortization of intangible assets | (241) | (256) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's diversified — SG&A?
- Bausch Health Companies (BHC) reported diversified — SG&A of $43M in Q1 2026.
- How has Bausch Health Companies's diversified — SG&A changed year-over-year?
- Bausch Health Companies's diversified — SG&A decreased by 4.4% year-over-year, from $45M to $43M.
- What is the long-term trend for Bausch Health Companies's diversified — SG&A?
- Over 3 years (2022 to 2025), Bausch Health Companies's diversified — SG&A has grown at a -7.1% compound annual growth rate (CAGR), from $211M to $169M.
- What does diversified — SG&A mean?
- Includes all operating expenses related to the sales, marketing, and general administrative support for the Diversified segment. This metric measures the cost efficiency of the segment's overhead and commercial infrastructure. Monitoring this helps investors evaluate how effectively the company manages its operating costs relative to revenue generation.
Ask your AI about Bausch Health Companies's diversified — sg&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude